205. Fragile X syndrome related disease Clinical trials / Disease details
Clinical trials : 5 / Drugs : 7 - (DrugBank : 5) / Drug target genes : 22 - Drug target pathways : 25
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00033293 (ClinicalTrials.gov) | March 15, 2004 | 9/4/2002 | Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma | A Pilot Study Randomized Trial of Intravenous Gammaglobulin Therapy for Patients With Neuroblastoma Associated Opsoclonus-Myoclonus-Ataxia Syndrome Treated With Chemotherapy and Prednisone | Disseminated Neuroblastoma;Localized Resectable Neuroblastoma;Localized Unresectable Neuroblastoma;Regional Neuroblastoma;Stage 4S Neuroblastoma | Biological: therapeutic immune globulin;Other: clinical observation;Drug: cyclophosphamide;Drug: prednisone;Procedure: magnetic resonance imaging;Other: laboratory biomarker analysis;Drug: Corticotropin-Releasing Hormone | Children's Oncology Group | National Cancer Institute (NCI) | Active, not recruiting | N/A | 8 Years | All | 53 | Phase 3 | United States;Australia;Canada;Netherlands;New Zealand;Puerto Rico;Switzerland |